Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT03145558
Title TATE Versus TACE in Intermediate Stage HCC (TATE)
Acronym TATE
Recruitment Suspended
Gender both
Phase Phase II
Variant Requirements No
Sponsors Teclison Ltd.
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.